DiCE Molecules

​Founded in 2013, DiCE Molecules is developing a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Our core technology was invented by Stanford Professor Pehr Harbury, a 2005 recipient of the Macarthur “genius” award. In addition to Professor Harbury, the founding team includes Dr. Phil Patten, formerly of Maxygen, Achaogen, and DuPont, who serves as our Chief Scientific Officer; Dr. John Bedbrook, a renowned serial entrepreneur in the agricultural biotechnology space, who is the Chairman of the DiCE Board of Directors; and Dr. Kevin Judice, who served various leadership roles at Genentech, Theravance, and Achaogen prior to joining DiCE as CEO.​​​